Total Valuation
Applied BioSciences has a market cap or net worth of $2.20K. The enterprise value is $273.68K.
Market Cap$2.20K
Enterprise Value$273.68K
Share Statistics
Applied BioSciences has 22,002,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,002,590
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Applied BioSciences’s return on equity (ROE) is 2.64 and return on invested capital (ROIC) is -99.07%.
Return on Equity (ROE)2.64
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-99.07%
Return on Capital Employed (ROCE)-1.18
Revenue Per Employee3.55K
Profits Per Employee-30.69K
Employee Count25
Asset Turnover0.07
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Applied BioSciences is ―. Applied BioSciences’s PEG ratio is 0.04.
PE Ratio―
PS Ratio30.92
PB Ratio-9.42
Price to Fair Value-9.42
Price to FCF-3.66
Price to Operating Cash Flow>-0.01
PEG Ratio0.04
Income Statement
In the last 12 months, Applied BioSciences had revenue of 88.67K and earned -767.22K in profits. Earnings per share was -0.04.
Revenue88.67K
Gross Profit-317.88K
Operating Income-692.76K
Pretax Income-899.67K
Net Income-767.22K
EBITDA-725.17K
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -933.90K and capital expenditures -1.55K, giving a free cash flow of -935.46K billion.
Operating Cash Flow-933.90K
Free Cash Flow-935.46K
Free Cash Flow per Share-0.04
Dividends & Yields
Applied BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta24.80
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)―
Important Dates
Applied BioSciences upcoming earnings date is Nov 15, 2019, Before Open (Confirmed).
Last Earnings DateAug 15, 2019
Next Earnings DateNov 15, 2019
Ex-Dividend Date―
Financial Position
Applied BioSciences as a current ratio of 0.01, with Debt / Equity ratio of -93.68%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap0.04
Net Debt to EBITDA-0.38
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Applied BioSciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Applied BioSciences EV to EBITDA ratio is -4.16, with an EV/FCF ratio of -4.02.
EV to Sales33.99
EV to EBITDA-4.16
EV to Free Cash Flow-4.02
EV to Operating Cash Flow-4.02
Balance Sheet
Applied BioSciences has $21.27K in cash and marketable securities with $914.52K in debt, giving a net cash position of -$893.25K billion.
Cash & Marketable Securities$21.27K
Total Debt$914.52K
Net Cash-$893.25K
Net Cash Per Share-$0.04
Tangible Book Value Per Share<$0.01
Margins
Gross margin is -358.52%, with operating margin of -781.32%, and net profit margin of -865.30%.
Gross Margin-358.52%
Operating Margin-781.32%
Pretax Margin-1014.68%
Net Profit Margin-865.30%
EBITDA Margin-817.88%
EBIT Margin-1014.68%
Analyst Forecast
The average price target for Applied BioSciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―